BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Enguita-Germán M, Fortes P. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. World J Hepatol 2014; 6(10): 716-737 [PMID: 25349643 DOI: 10.4254/wjh.v6.i10.716]
URL: https://www.wjgnet.com/1007-9327/full/v6/i10/716.htm
Number Citing Articles
1
Enas Mahmoud Moustafa, Laila Ahmed Rashed, Mohammed M. El-Sebaie, Noura Magdy Thabet, Mohamed Khairy Abdel-Rafei. Crosstalk between ER-stress and apoptosis in irradiated HepG2 cells with gemcitabine: implication of PI3K/AKT and IκB/NF-κB signaling pathwaysJournal of Radiation Research and Applied Sciences 2020; 13(1): 144 doi: 10.1080/16878507.2020.1715569
2
Astrid A. Glück, Daniel M. Aebersold, Yitzhak Zimmer, Michaela Medová. Interplay between receptor tyrosine kinases and hypoxia signaling in cancerThe International Journal of Biochemistry & Cell Biology 2015; 62: 101 doi: 10.1016/j.biocel.2015.02.018
3
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, Henrike Lenzen, Michael P. Manns, Tetyana Yevsa. Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancersHuman Vaccines & Immunotherapeutics 2017; 13(12): 2931 doi: 10.1080/21645515.2017.1359362
4
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapyMaterials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
5
Enakshi Sivasudhan, Neil Blake, Zhi-Liang Lu, Jia Meng, Rong Rong. Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.642443
6
Sun-Min Lee, Jeongsil Kim-Ha, Won-Young Choi, Jungwoo Lee, Dawon Kim, Jinyoung Lee, Eunji Choi, Young-Joon Kim. Interplay of genetic and epigenetic alterations in hepatocellular carcinomaEpigenomics 2016; 8(7): 993 doi: 10.2217/epi-2016-0027
7
Jianghong Cheng, Yanhong Zhong, Shuai Chen, Yan Sun, Lantang Huang, Yujia Kang, Baozhen Chen, Gang Chen, Fengli Wang, Yingpu Tian, Wenjie Liu, Gen‐Sheng Feng, Zhongxian Lu. Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathwaysThe FASEB Journal 2017; 31(12): 5530 doi: 10.1096/fj.201700120RR
8
Lizhi Xiao, Enhua Xiao. Blood oxygen level–dependent functional magnetic resonance imaging can evaluate the efficiency of transcatheter arterial chemoembolization in hepatocellular carcinomaJournal of Interventional Medicine 2019; 2(1): 5 doi: 10.1016/j.jimed.2019.05.002
9
David Prince, Ken Liu, Weiqi Xu, Minjiang Chen, Jin-Yu Sun, Xiao-Jie Lu, Jiansong Ji. Management of patients with intermediate stage hepatocellular carcinomaTherapeutic Advances in Medical Oncology 2020; 12: 175883592097084 doi: 10.1177/1758835920970840
10
Fabio Nascimbeni, Judith Aron-Wisnewsky, Raluca Pais, Joan Tordjman, Christine Poitou, Frederic Charlotte, Pierre Bedossa, Thierry Poynard, Karine Clément, Vlad Ratziu. Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver diseaseBMJ Open Gastroenterology 2016; 3(1): e000075 doi: 10.1136/bmjgast-2015-000075
11
Jameel Al-Tamimi, Abdelhabib Semlali, Iftekhar Hassan, Hossam Ebaid, Ibrahim M. Alhazza, Syed H. Mehdi, Mohammed Al-Khalifa, Mohammad S. Alanazi. Samsum Ant Venom Exerts Anticancer Activity Through Immunomodulation In Vitro and In VivoCancer Biotherapy and Radiopharmaceuticals 2018; 33(2): 65 doi: 10.1089/cbr.2017.2400
12
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open questionWorld Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
13
Melchiorre Cervello, Giuseppa Augello, Antonella Cusimano, Maria Rita Emma, Daniele Balasus, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto. Pivotal roles of glycogen synthase-3 in hepatocellular carcinomaAdvances in Biological Regulation 2017; 65: 59 doi: 10.1016/j.jbior.2017.06.002
14
Li Chen, Yundong Wei, Shimei Zhao, Mengliang Zhang, Xiaoting Yan, Xiangyun Gao, Jinxia Li, Yutong Gao, Anwen Zhang, Ying Gao. Antitumor and immunomodulatory activities of total flavonoids extract from persimmon leaves in H22 liver tumor-bearing miceScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28440-8
15
Md Gulam Musawwir Khan, Amit Ghosh, Bhavesh Variya, Madanraj Appiya Santharam, Awais Ullah Ihsan, Sheela Ramanathan, Subburaj Ilangumaran. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07285-3
16
Go J. Yoshida, Arata Azuma, Yukiko Miura, Akira Orimo. Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic StrategiesInternational Journal of Molecular Sciences 2019; 20(9): 2256 doi: 10.3390/ijms20092256
17
Pasquale Agosti, Carlo Sabbà, Antonio Mazzocca. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironmentBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(2): 607 doi: 10.1016/j.bbadis.2017.11.026
18
Masahito Shimizu, Yohei Shirakami, Hiroyasu Sakai, Masaya Kubota, Takahiro Kochi, Takayasu Ideta, Tsuneyuki Miyazaki, Hisataka Moriwaki. Chemopreventive Potential of Green Tea Catechins in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2015; 16(12): 6124 doi: 10.3390/ijms16036124
19
Chuan Chen, Ge Wang. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapyWorld Journal of Hepatology 2015; 7(15): 1964-1970 doi: 10.4254/wjh.v7.i15.1964
20
Jean-Charles Nault. Reports from the International Liver Cancer Association (ILCA) congress 2014Journal of Hepatology 2015; 62(2): 477 doi: 10.1016/j.jhep.2014.11.015
21
Vladimir M. Subbotin. Privileged portal metastasis of hepatocellular carcinoma in light of co-evolution of a visceral portal system and the liver in the chordate lineage: a search for therapeutic targetsDrug Discovery Today 2018; 23(3): 548 doi: 10.1016/j.drudis.2018.01.020
22
Fang Wang, Thomas Bank, Gregory Malnassy, Maribel Arteaga, Na Shang, Annika Dalheim, Xianzhong Ding, Scott J. Cotler, Mitchell F. Denning, Michael I. Nishimura, Peter Breslin, Wei Qiu. Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survivalHepatology Communications 2018; 2(6): 732 doi: 10.1002/hep4.1181
23
Zheng Lou, Yong‑Qiang Gong, Xing Zhou, Guo‑Huang Hu. Low expression of miR‑199 in hepatocellular carcinoma contributes to tumor cell hyper‑proliferation by negatively suppressing XBP1Oncology Letters 2018;  doi: 10.3892/ol.2018.9476
24
Xuefeng Wang, Liangyu Lin, Bin Lan, Yu Wang, Liming Du, Xiaodong Chen, Qing Li, Keli Liu, Mingyuan Hu, Yueqing Xue, Arthur I. Roberts, Changshun Shao, Gerry Melino, Yufang Shi, Ying Wang. IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophagesScience Advances 2020; 6(48) doi: 10.1126/sciadv.abb7389
25
J.M. Redman, E.M. Hill, D. AlDeghaither, L.M. Weiner. Mechanisms of action of therapeutic antibodies for cancerMolecular Immunology 2015; 67(2): 28 doi: 10.1016/j.molimm.2015.04.002
26
Hyuk Moon, Simon Weonsang Ro. MAPK/ERK Signaling Pathway in Hepatocellular CarcinomaCancers 2021; 13(12): 3026 doi: 10.3390/cancers13123026
27
Maysa A. Mobasher, Mousa O. Germoush, Hala Galal El-Tantawi, Karim Samy El-Said. Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus RatsPathogens 2021; 10(1): 59 doi: 10.3390/pathogens10010059
28
Hamid Ceylan. Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysisMedical Oncology 2021; 38(6) doi: 10.1007/s12032-021-01510-0
29
Hongyan Liu, Hong Xu, Chenghong Zhang, Meng Gao, Xiaoguang Gao, Chuchu Ma, Li Lv, Dongyan Gao, Sa Deng, Changyuan Wang, Yan Tian. Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver CancerPharmaceutical Research 2016; 33(11): 2828 doi: 10.1007/s11095-016-2010-5
30
Luciano Sobrevals, Mónica Enguita, Jorge Quiroga, Jesús Prieto, Puri Fortes, Joseph Charles Glorioso. Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in RatsPLOS ONE 2016; 11(9): e0162955 doi: 10.1371/journal.pone.0162955
31
A.P. Alves, A.C. Mamede, M.G. Alves, P.F. Oliveira, S.M. Rocha, M.F. Botelho, C.J. Maia. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?Current Cancer Drug Targets 2018; 19(1): 26 doi: 10.2174/1568009618666180430144441
32
Yachao Tao, Menglan Wang, Enqiang Chen, Hong Tang. Liver Regeneration: Analysis of the Main Relevant Signaling MoleculesMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/4256352
33
Manar Salah El-Din, AlShaimaa Mohamed Taha, Ahmed Abdel-Aziz Sayed, Ahmed Mohamed Salem. Ziziphus spina-christi leaves methanolic extract alleviates diethylnitrosamine-induced hepatocellular carcinoma in ratsBiochemistry and Cell Biology 2019; 97(4): 437 doi: 10.1139/bcb-2018-0318
34
Catia Lippolis, Maria Grazia Refolo, Rosalba D’Alessandro, Nicola Carella, Caterina Messa, Aldo Cavallini, Brian Irving Carr. Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0210-1
35
Chuanzong Zhao, Qian Wang, Ben Wang, Qi Sun, Zhaobin He, Jianguo Hong, Florian Kuehn, Enyu Liu, Zongli Zhang. IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinomaOncotarget 2017; 8(67): 111922 doi: 10.18632/oncotarget.22952
36
Vladimir M. Subbotin. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?Medical Hypotheses 2019; 126: 109 doi: 10.1016/j.mehy.2019.03.019
37
Koji Fujita, Hisakazu Iwama, Hisaaki Miyoshi, Joji Tani, Kyoko Oura, Tomoko Tadokoro, Teppei Sakamoto, Takako Nomura, Asahiro Morishita, Hirohito Yoneyama, Tsutomu Masaki. Diabetes mellitus and metformin in hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(27): 6100-6113 doi: 10.3748/wjg.v22.i27.6100
38
Mustafa A. Barbhuiya, Adam C. Mirando, Brian W. Simons, Ghali Lemtiri-Chlieh, Jordan J. Green, Aleksander S. Popel, Niranjan B. Pandey, Phuoc T. Tran. Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinomaOncotarget 2017; 8(60): 101520 doi: 10.18632/oncotarget.21148
39
Maria Roméria da Silva, Gabriela Alves Moreira, Ronni Anderson Gonçalves da Silva, Éverton de Almeida Alves Barbosa, Raoni Pais Siqueira, Róbson Ricardo Teixera, Márcia Rogéria Almeida, Abelardo Silva Júnior, Juliana Lopes Rangel Fietto, Gustavo Costa Bressan. Splicing Regulators and Their Roles in Cancer Biology and TherapyBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/150514
40
Marie Boyle, Jelena Mann. WITHDRAWN: Epigenetics in Chronic Liver DiseaseJournal of Hepatology 2017;  doi: 10.1016/j.jhep.2017.08.016
41
Bryan Fleming, Mitchell Ho. Glypican-3 Targeting Immunotoxins for the Treatment of Liver CancerToxins 2016; 8(10): 274 doi: 10.3390/toxins8100274
42
Hong Li, Xiumei Jiang, Shengjie Zhu, Lihong Sui. Identification of personalized dysregulated pathways in hepatocellular carcinomaPathology - Research and Practice 2017; 213(4): 327 doi: 10.1016/j.prp.2017.01.015